A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

BACKGROUND: Olanzapine rapid-acting intramuscular (IM) injection is an atypical antipsychotic drug already used overseas and recently approved in Japan. The objective of this study was to confirm the efficacy of rapid-acting IM olanzapine 10 mg was greater than IM placebo in patients with exacerbati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Katagiri, Hideaki, Fujikoshi, Shinji, Suzuki, Takuya, Fujita, Kiyoshi, Sugiyama, Naoya, Takahashi, Michihiro, Gomez, Juan-Carlos
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2013
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556331/
https://ncbi.nlm.nih.gov/pubmed/23311957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-13-20
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge